High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC: Possible Poor Prognostic Factors.

TitleHigh Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC: Possible Poor Prognostic Factors.
Publication TypeJournal Article
Year of Publication2012
AuthorsLin X-F, Wang X-D, Sun D-Q, Li Z, Bai Y
JournalCancer biology & medicine
Volume9
Issue4
Pagination270-3
Date Published2012 Dec
Abstract

The aim of this study was to test whether carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA21-1) can be used as a prognostic factor for non-small-cell lung cancer (NSCLC) after two cycles of adjuvant chemotherapy in NSCLC patients.

DOI10.1155/2013/979702
Alternate JournalCancer Biol Med